The time for the use of Artificial Intelligence (AI) in Fleet Management is long past – It’s now imperative to the long-term success and continued growth of every company. Companies that successfully implement AI-driven logistics can maximize their operational efficiency and productivity.
Companies that use AI to streamline workflows can make smarter decisions about resource allocation, ultimately increasing operational efficiency and creating a competitive advantage. Companies that implement AI in their fleets will continue to lead the industry in Fleet Technology advancements. The role of AI in Fleet Management will continue to evolve as AI advances, with limitless potential to drive new technologies.
One way an individual’s genomic data can be used to improve care is through a field called pharmacogenomics. Through this research, pharmacogenomics examines the relationship between an individual’s genetic profile and their reaction to drugs, ultimately allowing doctors to provide the most suitable drug available for an individual while reducing adverse reactions.
Pharmacogenomics has made a significant impact on improving cancer treatment as it provides doctors with the genetic information required to develop treatment plans that are more beneficial for the specific type of tumor an individual is afflicted with.
Beyond identifying genetic causes of a multitude of diseases, genomic data will also help scientists determine whether individuals have a genetic predisposition to disease. Scientists will analyze genomic data from an entire population and identify genetic markers associated with increased susceptibility to various diseases (e.g., diabetes, heart disease, cancer).
The importance of Genomic Data Analysis for preventive healthcare lies in an individual’s ability to use genetic information to make lifestyle decisions and receive screenings for diseases to which they are genetically predisposed.
Although Genomic Data Analysis has significant potential due to the complexity of the large volumes of genomic data being generated, It also presents several challenges. To analyze this large volume of genomic data and develop meaningful relationships or correlations, current analytical methodologies require advanced tools (such as Artificial Intelligence [AI] and Machine Learning).
With increased access to genomic data comes new concerns about privacy and ownership. As an individual consents to the analysis of his/her genomic data, questions regarding who will control the genomic data and how it will be used become relevant.
#Empowering Smart Wearables and AI: How They Track Your Health
Global Genomic Data
Source: Nature Biotechnology, National Human Genome Research Institute (NHGRI), EMBL-EBI Genomics Data Growth Reports
Modern medicine has many uses of genomic data as it gives us a better look into our overall health and diseases than ever before. Additionally, genomic data allow us to use a person’s genetic code to provide personalized medicine, determine our risk of developing a disease based on our genetic makeup, and make informed health care decisions. These are just a few examples of how genomic data is changing the way medicine works today.
Genomics will be a major player in the medical field for many years to come and will drive the creation of the next generation of medicine.
Have you ever been sitting in a doctor’s office waiting for a diagnosis? Traditionally, medicine diagnosed conditions based on a patient’s symptoms and family medical history. But what if your doctor had access to your “blueprint” of your body (your genetic code) and a very smart computer system to help identify potential health issues before they develop?
A future once considered science fiction is now a reality as we begin combining genomic data with artificial intelligence (AI).
The biggest problem with all biological blueprints is size. The number of letters in a person’s complete genetic map or genome exceeds 3 billion. If someone were to print their entire genome, the stack of paper would be 200 feet tall, according to the National Human Genome Research Institute.
Consequently, no team of researchers would have time to review the enormous volumes of information in genomic libraries to identify the relatively small but important genetic map variations associated with specific diseases.
Artificial intelligence in healthcare will provide a solution by allowing for the training of AI models to analyze large genomic databases. Using AI, we can evaluate large numbers of genomic libraries simultaneously to identify patterns that correlate with various diseases, including cancers and Alzheimer’s disease. Combining genomic data and artificial intelligence will allow us to move from treating illnesses to preventing them.
Largest Global Genomic Databases Used for AI Training
Source: UK Biobank, NIH All of US Program, Broad Institute (gnomAD), Nature Genetics
What Is a Genome, and Why Is It More Than Just Your Genes?
Many of us associate our DNA with the genetic code that provides the blueprint for the traits we inherit from our parents, including eye color, hair color, height etc. It can help to visualize a gene as a single recipe in an infinitely long cookbook. A gene would provide the recipe for creating the pigment for your eyes.
Another gene would provide the recipe for how your body breaks down sugars. Even though they are significant, genes are only part of the bigger picture.
Using the same analogy and assuming a gene is a single recipe in the book of recipes, then your genome would include every book in the cookbook (i.e., all of the instructions needed to build and run you).
You have approximately 3 billion letters in your genome that use a 4-letter alphabet (A, C, G & T) that determine the order in which those letters are arranged in sequence that ultimately defines who you are.
Not only do your genes contain the instructions for your physical characteristics, but also potentially the risk of developing certain diseases, and how your body will react to medication, so reading through a library of this size is quite the task.
The Ultimate ‘Big Data’ Problem: Why Can’t Humans Just Read the Genome?
To everyone’s surprise, the major issue has not been reading an individual’s genetic code; rather, the greatest challenge is now comparing the genetic code of thousands or millions of people side by side to determine which of the many genetic variations affect their health.
At this juncture, the task has shifted from being extremely difficult to be fundamentally impossible for humans to accomplish.
To put into perspective the enormity of the task involved in comparing genetic data, consider the following example in a relatively simplistic way:
- Finding one typo in two sentences? Almost everyone can do this easily.
- Locating a single word that is different on the pages of two separate books? This is also possible if you have enough time.
- Finding a single spelling error across all libraries (including the New York Public Library), which comprises approximately 10,000 collections, is the true size of the task at hand in today’s genomics research.
Genetic researchers are searching for the subtle patterns (slight variations from the normal genetic code) of individuals with Alzheimer’s disease (and other diseases), and not in those who do not have these diseases. The genetic researchers’ large-scale comparisons will enable them to unravel the mysteries of disease.
This is ultimately the largest “big data” challenge. The considerable time required to compare all these “books” over many years has limited researchers’ ability to translate their scientific discoveries into medical treatments as quickly as they might wish.
No matter how smart or talented an investigator may be, he/she will never be able to compare the vast amounts of data in genomics at a rapid pace. We need a new tool to help us compare all the “books” in every library at once and identify patterns we can’t detect on our own.
AI in Genomics: Transforming How We Understand DNA
“A.I. in Genomics: A New Paradigm for Analyzing Genomic Data with Artificial Intelligence” is a novel approach to using artificial intelligence to analyze very large amounts of genomic data. A.I. in genomics helps researchers analyze vast databases of genetic information and identify complex patterns that are difficult or impossible for humans to recognize.
The paradigm in our understanding of DNA not only accelerates the rate of new discoveries but also gives us greater insights into the complexity of biological systems.
The integration of A.I. into genomics allows researchers to identify key genetic markers associated with disease states. Using A.I. algorithms, subtle variations in genomic data across populations can be identified, which may indicate an increased risk of developing certain diseases.
#How IoT Works in Hospitals: IoMT is Revolutionary & Lifesaving
This type of ability will have a profound impact on the practice of personalized medicine; with AI assisting in genomic analysis, it will enable the development of treatments specific to an individual’s unique genetic signature.
AI is also going to significantly affect how quickly new medicines can be developed, given the time required. In the past, developing new drugs was a slow, very expensive process, with clinical trial results typically taking many years to emerge. With the assistance of AI, scientists can run simulations of thousands of potential drug combinations against an individual’s genomic data; thus, the time required to find a suitable drug combination may be reduced from years to weeks.
The ability to focus on many genetic conditions at once enables more efficient research into treatments for conditions resulting from genetic disorders, which might otherwise be overlooked due to small numbers of affected individuals.
Genomic AI will also enable predictive analysis. Through genomic data analysis, AI can provide models to predict an individual’s risk of developing certain disease states. Also, by predicting an individual’s risk of developing certain disease states, we will empower that individual to make proactive decisions regarding their health care, thus moving us closer to shifting from a reactive model of healthcare to a preventative model.
Overall, the combination of genomic data with AI technology has transformed our understanding of DNA, advanced personalized medicine, accelerated the development of new drugs, and led to a move towards a proactive model of healthcare. The future of genomics is bright and appears limitless, driven by AI-enabled advancements in the field.
Real – World Examples of AI Genomics Companies
Source: Nature Biotechnology, MIT Technology Review, Company reports
How AI Becomes a ‘Super-Powered Pattern Finder’ for Our Genes
This is when AI can aid researchers in identifying patterns in DNA data by determining the most probable pattern(s) based on their maximum probability rather than by means of reasoning (or consciousness). The way in which AI identifies patterns in DNA data may be illustrated by a spell checker that can find spelling errors far faster than you can read a single word.
Like a spell checker, the AI will not need to understand the meaning behind your words to find a misspelling; it simply needs to know what is the correct spelling and then quickly identify all misspellings. Similarly, AI can evaluate billions of DNA bases from tens of thousands of individuals to identify small, consistent differences that are too subtle for a human eye to detect.
Researchers have also found a way to use this process to train the AI through a learning process that is similar to the one used to train an individual to recognize different animals. Instead of teaching the AI biological laws, the researchers use thousands of examples to “train” the AI.
for example, researchers may give the AI the genetic code of 50,000 people who have cancer and another 50,000 people who do not have cancer. The researchers want the AI to create a complete picture of how and why cancer occurs.
the researcher wants the AI to find out if in the first group (people with cancer) the AI can find unique genetic patterns (i.e., unique patterns of genes) that appear in the first group but are not found in the second group (the people without cancer).
Once the AI has identified at least one unique genetic pattern in the first group, the researchers will have identified the biomarker. Biomarkers are biological indicators of health, often represented by a biological “signpost”, or “check engine light”, in your DNA.
These signposts can represent a higher risk of developing a certain disease, a better way to predict your response to certain drugs, and/or the possible origin of a tumor. Identifying biomarkers marks the beginning of a new era of medicine, where treatments are developed based on your specific genetic profile rather than using a “one size fits all” approach.
AI Genomics: Where Biology Meets Intelligent Systems
AI Genomics — “Where Intelligent Systems Meet Biological Data” — is a relatively new area of study that combines the potential of artificial intelligence with the complexity of biology. In this emerging area of research, researchers applying AI to genomics are changing the way we collect, analyze, and interpret genomic data and have established pathways to make significant improvements in health care and disease management. By integrating intelligent systems with vast amounts of biological data, we have made it possible to analyze genomic data much faster and more efficiently than previously possible.
Utilizing AI Genomics to examine genomic data from many different populations provides researchers an opportunity to identify new associations in biological processes. Machine learning can also be used in AI Genomics, enabling researchers to determine whether a particular genetic variant is associated with a disease, helping them better understand the complexity of diseases such as cancer and diabetes. Understanding a patient’s genetic makeup will enable the development of targeted therapeutic interventions based on the patient’s unique genetic profile.
Genomics with artificial intelligence (AI) has enabled scientists to accelerate their work by analyzing large genomic datasets more quickly than they could traditionally. Traditional analysis of genomic data can be very time-consuming and delay progress. Many laborious tasks associated with traditional analysis are automated by AI-based tools, enabling scientists to draw meaningful conclusions from their data without spending excessive time on analysis.
The applications of AI Genomics are vast. It is used to help scientists develop better drugs and to improve the accuracy of diagnostic tests. It is also changing the way personalized medicine is practiced. Using genomic data effectively will enable health care providers to offer patients treatment options based on their unique genetic profiles, thereby improving outcomes.
To summarize, AI Genomics is at the forefront of modern biological research as a tool for applying genomic data to intelligent systems. The combination of these two technologies is enhancing our knowledge of biology and allows us to envision how we will improve the delivery of health care in the future by making it more personalized and efficient. The continued growth of AI Genomics will create opportunities for scientists to better understand life at the genomic level.
Impact of Genomic AI on Healthcare Outcomes
Source: World Health Organization, Stanford Center for Genomics and Personalized Medicine
AI Data Analysis: Making Sense of Massive Genomic Datasets
“AI Data Analysis: The Mountains of Genomic Data” adds a new dimension to genomics, highlighting the opportunities and challenges posed by the large volumes of genomic data for analysis.
As genomic sequencing technology continues to evolve, so does the need to develop methods to efficiently process and analyze the large volumes of data it produces. In response to this challenge, AI data analysis is becoming a valuable tool for genomic data analysis, utilizing machine learning algorithms to quickly and accurately identify and extract large amounts of genomic data.
In addition to identifying the relationship between a single genetic variant and a disease, AI-driven genomic data analysis could drive breakthroughs in the development of personalized medicine. Ultimately, AI will enable researchers to interpret their own genomic data, rather than being overwhelmed by the sheer volume of the data collected.
“AI data analysis enables more comprehensive use of Genomic data:
Genetic information analysis with AI will enable the integration of different types of genetic data (e.g., Gene expression profiles and SNP data), ultimately leading to a greater understanding of the biological pathways involved in health disorders.
Identification of new biomarkers for early detection of diseases and development of treatment strategies via AI data analysis;
Faster drug discovery via AI data analysis – this technology allows researchers to quickly analyze large volumes of Genomic data to identify possible therapeutic targets and develop new treatments. Rapid discovery cycles for identifying therapeutic targets and developing drugs are particularly important in the treatment of rare diseases, where early results can have a dramatic impact on patients’ lives.
Therefore, AI data analysis is a revolutionary technology that allows researchers to make sense of the large amounts of Genomic data that exist today.
AI Accuracy in Genomic Disease Detection
Source: Nature Medicine, The Lanced Digital Health, Stanford AI in Healthcare Research
Genomic Machine Learning: Teaching AI to Learn from DNA
Genomic Machine Learning (GML) is an emerging field of research that uses advanced machine learning techniques to identify relationships in genomic data. Genomic Machine Learning enables scientists to process large-scale genomic datasets by combining genomics and machine learning.
Machine learning techniques are used to develop algorithms to uncover patterns or relationships in genomic information. Researchers train artificial intelligence (AI) models on diverse datasets, enabling them to identify associations between the genome and various diseases or conditions.
Research utilizing Genomic Machine Learning has accelerated new discoveries and the development of more accurate predictive models of disease susceptibility and treatment response.
A major benefit of Genomic Machine Learning is the rapid processing of large quantities of genomic data. Traditional analytical methods have often struggled to process the vast amounts of data generated by modern high-throughput technologies, resulting in delays in scientific progress.
The process of deriving meaningful conclusions from study results that were previously time-consuming has been made easier by Genomic Machine Learning.
Healthcare providers will use genomic data to develop personalized treatments for each patient based on their specific genetic profile.
A true milestone in the development of medical care has occurred with the movement toward a “custom fit” approach rather than the “one size fits all” approach.
In addition to medical applications, genomic machine learning has the potential to benefit several other fields, including agriculture, biotechnology, and evolutionary biology, demonstrating its ability to address a wide range of problems.
Genomic machine learning is transforming how AI learns from DNA and genomic data; therefore, genomic data can be analyzed using machine learning to generate insights into the future of genomics, identify new areas of investigation, enhance health outcomes, and develop future treatment options.
Genomic Insights: Unlocking Hidden Patterns in DNA
“Unlocking Hidden Patterns in DNA Using Genomic Insights: A New Approach to Elucidate Complexity in Human Biology and Disease” outlines a new approach to understanding the complexities of human biology and disease.
Using advanced statistical and analytical tools, investigators can leverage large-scale genomic databases to identify hidden genomic patterns that may contribute to an individual’s overall health and disease status. With the growing importance of genomic analysis in developing personalized medicine and gaining deeper insights into biological processes, the use of genomic studies will continue to expand.
Analysis of genomic data has provided scientists with a basis for examining the association between genetic markers and disease in large population groups, to determine whether specific genetic markers are associated with increased susceptibility to disease, as well as in other areas of genetics and pharmacogenomics.
Analysis of genomic data has enabled scientists to develop evidence-based predictive models of disease risk, facilitating the efficient delivery of effective treatments to at-risk individuals and thereby improving the efficiency and effectiveness of healthcare delivery.
Genomic data, through the development of predictive models based on genetic information obtained from individuals, provides insight into the interaction between genetic predispositions and environmental influences, yielding a much greater understanding of the factors that contribute to health.
#Intelligent Smart IoT Sensors and AI: The Powerful Connection
Genomics is a resource for far more than just people’s health and will likely be an essential tool in agricultural science and conservation biology. For instance, we will have a better understanding of the genetic makeup of endangered crops and species. This will allow us to develop better ways to manage these resources, helping us conserve biodiversity.
By combining AI with Machine Learning and Genomic Data, we can quickly and effectively uncover genomic insights from large datasets. The ability to use these tools will also allow researchers to rapidly analyze large datasets to identify key genomic insights that may potentially lead to new treatments or interventions.
Beginning with an overall assessment, we can see that genomic insight will enable new models of DNA and provide a wealth of information to advance both medicine and biology.
Genomic analysis will become more accurate and efficient, resulting in a better understanding of genetic makeup and helping us identify and treat a wider variety of health issues. The possibilities are limitless with the power of genomic insight, as it has introduced a whole new world of scientific and medical discovery.
Genomic Analytics: Turning Genetic Data into Actionable Knowledge
The goal of genomic analytics is to convert raw genomic data from individuals or populations into usable information that helps medical professionals and researchers make better-informed decisions.
Computational methods are used to convert large volumes of complex genetic data into usable knowledge. These computational methods include sophisticated algorithms and statistical models that enable researchers and clinicians alike to translate large volumes of complex genetic data into actionable knowledge. As such, genomics analytics is one of the foundational tools that will be used in many future advancements in personalized medicine, as well as in our general understanding of disease causes.
A systematic analytical approach is used to evaluate genomic data from experiments, including but not limited to DNA sequencing, RNA expression measurements, and epigenetic modifications.
These experiments generate a vast amount of data about how biological systems function and how disease progresses. Additionally, genomic analytics can be used to identify patterns and relationships in data generated by these experiments that would be difficult to detect with other analytical approaches.
Another benefit of genomic analytics is its ability to identify genetic variants that may increase an individual’s risk of developing specific health problems.
Researchers have shown they can match genetic markers in genomic data to specific clinical outcomes, building predictive models to identify which patients are at the highest risk of adverse health effects.
Identifying who is at risk allows Healthcare Providers to develop tailored preventative measures and provide personalized treatment to meet the individual needs of each patient, leading to improved health results.
Genomics has numerous uses beyond human health, including agriculture and evolutionary biology. For example, Genomic Analysis can be utilized in crop improvement through breeding programs to identify those traits associated with crop yield and disease resistance.
Similarly, genomic analysis can be used to assess the level of genetic diversity in endangered species and to inform the design of effective conservation strategies.
Genomic Analysis translates genomic data into actionable information. Genomic Analysis also encompasses the ability to analyze and understand genomic data, enabling researchers to provide insights, improve health outcomes, and drive innovation across multiple fields.
As the field of Genomic Analytics continues to grow, it will be increasingly important in evolving and improving our understanding of the relationship between genetics and humanity.
From Guesswork to Guarantee: How AI Enables Personalized Medicine
The precision of medicine has also improved due to the identification of specific genes that lead to a diagnosis. For many years, treatments for illnesses were somewhat one-size-fits-all, like a car mechanic who used the same three tools on every car he worked on, regardless of make or model.
Precision Medicine allows physicians to treat you as an individual with an illness, as opposed to treating groups of individuals with similar symptoms. It is very much the same as the difference between purchasing clothing off the rack and having it custom-made to fit your body perfectly.
Precision medicine can only be accomplished through the use of AI to process information. Once a biomarker is identified in your genome, an AI system can match it against vast amounts of data from your medical history.
Genomic machine learning has allowed doctors to ask a new, and highly powerful question as well: “What drug was proven to be the most successful with the fewest negative side effects for a person with your unique genetic makeup?” In essence, the AI acts like a super-intelligent research assistant that compares thousands of historical cases to figure out what drug(s) would provide the greatest benefit to you.
Cancer Treatment is where it will have the greatest impact. Chemotherapy has always been an “all or nothing” type of treatment. It kills ALL cells (both cancerous and non-cancerous).
Using artificial intelligence (AI) to create personalized medicine, we can now analyze the unique genetic makeup of a patient’s tumor to identify its specific weak point (its “Achilles heel”). We can then use targeted therapy – a new group of “smart drugs” designed to attack only the tumor’s weak point – providing a much more effective treatment while causing less harm to the remaining healthy parts of the body.
AI-Driven Personalized Medicine Adoption
Table showing regional adoption of genomic AI in healthcare, including the United States, Europe, China, and the global average, with main use cases such as precision oncology and personalized medicine.
Spotting the Shadow: Using AI to Predict Genetic Diseases Years in Advance
Because most chronic diseases (Alzheimer’s and heart disease are examples), there is no single “disease gene,” but rather numerous genes acting in combination, creating the probability of the development of a disease at some point in the future; By comparing millions of genomes,
AI can create an algorithm that identifies combinations of many low-level genetic changes that indicate an increased risk of developing a disease in the future. In other words, AI’s ability to predict genetic disease represents a biological early-warning system (or biological smoke detector), allowing clinicians to identify potential problems well before they become a clinical diagnosis.
What an exciting opportunity to revolutionize how we approach managing health in the face of disease. We are moving from a reactive model of managing disease (treating it only after it develops and is diagnosed) to a proactive model called Proactive Health Care. For example, when you discover you are genetically predisposed to high cholesterol, that does not mean you have to succumb to this diagnosis — instead, you can utilize the knowledge you have learned as a result of your discovery to prevent the development of high cholesterol.
The information obtained via Deep Learning will enable you to identify the knowledge needed to collaborate with your doctor to create a personalized preventive plan (diet/exercise regimen, etc.) that will likely include additional screening(s). The future of artificial intelligence in healthcare will offer much more than improved treatment options for those in need — it will enable many fewer treatments, and potentially eliminate them altogether.
The new technology will also have a huge impact on families with a genetic illness in their family history. The families that have members who are sick due to a genetic illness will no longer have to worry about whether their children or grandchildren will get the same disease as them.
Instead of being uncertain about whether they will contract a disease based on genetics, people will know their risk of developing a disease and what they can do to avoid it. Instead of asking “Will I get this disease?”, people will ask “What can I do today to keep from getting this disease?” Having an artificial intelligence assist in providing a comprehensive look at our biological makeup will allow us to make choices that determine our own health future.
Supercharging the Lab: How AI Makes New Drug Discovery 10x Faster
Traditional drug development was like finding the right single key that fits into a lock. With each molecule being unique and with literally hundreds of thousands of different drugs, it is like having a million keys on a chain. For decades, scientists have used laboratories to test numerous chemical compounds at a cost of billions of dollars, only to have a small chance that one will work. It is this trial and error process that has caused it to often take 10 plus years to create a new medication.
The application of deep learning has made it much faster to discover drug targets through virtual screening, enabling the examination of millions of potential drugs. Scientists first need to find what is known as a drug target; essentially, the lock on the disease-causing cells. Next, they use artificial intelligence to digitally model potential drug molecules (the keys) that could potentially fit into the drug target.
This enables the scientist to bypass manual testing of every compound that may have been beneficial, thereby narrowing the list to those most likely to yield positive results in a laboratory setting.
The use of Deep Learning has greatly accelerated progress in genetics. Possibly the greatest advantage of Deep Learning in Genetics is its potential to address the tens of thousands of rare genetic diseases that affect millions of people.
Whereas Big Data has enabled scientists to discover rare genetic targets, AI has enabled the rapid discovery of potential treatments for these diseases. In doing so, AI has enabled scientists to offer hope to families suffering from a rare genetic disease by making it possible to discover a treatment for their loved one’s condition. That is, while it previously took scientists up to 10 years to find a potential treatment for a rare genetic disease, AI has reduced this timeframe to several weeks.
Time Reduction in Drug Discovery Using AI Genomics
Source: McKinsey Global Institute, Deloitte Life Sciences AI Report, Nature Drug Discovery
The Double-Edged Sword: Protecting Your Most Personal Data
Genomic data is extremely personal and has high potential for use with artificial intelligence in medicine, but it is also highly personally identifiable. You cannot change your genetic code like you can a stolen password. Genomic data does not just provide current information about your health status; it also provides predictions about future health risks as well as those of your biological family members.
The volume of genomic data presents a significant obstacle to analysis and protection, posing a major barrier to genomic data protection.
In addition to the risk of genomic data breaches due to hacking there are deep ethical implications to the use of AI in genetics, the primary issue in the use of AI in genetics is genetic discrimination. Genetic discrimination occurs when an individual is discriminated against due to their genetic information.
For example, if insurance companies raise your rates because your genome shows that you have a higher likelihood of developing heart disease, or if a potential employer does not select you for a job because your genome contains a marker for a neurological condition that may never occur in your lifetime. Both of these examples are realistic and currently the subject of legal and ethical debate.
The international conversation that has emerged regarding concerns about genetic discrimination with the advent of Artificial Intelligence (AI) in genetics has initiated a dialogue to develop laws and regulatory guidelines to define the direction of AI in the healthcare industry. Ethicists, scientists, and lawmakers are working together to create a framework that enables the continued advancement of genomics while protecting individual rights.
At this time, we are experiencing a great deal of discussion at the foundational level regarding:
- Who owns my genomic information once I’ve had my genome sequenced?
- What protections are in place to safeguard my genomic information from hackers?
- Will insurance companies and/or my employer be able to utilize my genomic information as a means of discriminating against me?
Cost Reduction in Genome Sequencing
Source: National Human Genome Research Institute (NHGRI)
Why AI Needs Genomic Data for Future Breakthroughs
The urgency of making genomic data available to support future advancements in Artificial Intelligence (AI) has never been greater, as we enter an entirely new age in which AI will significantly impact how we think about Health & Disease. The genomic data, therefore, represents the fundamental biological information needed to successfully train AI systems.
The development of AI algorithms that utilize genomic data enables the vast amount of genomic data to be used to identify and correlate patterns in massive datasets; these discoveries include genetic variants that cause disease and lead to Personalized Medicine.
In addition, as AI systems receive more genomic data, they can make predictions with increasing accuracy and sensitivity. Ultimately, the ability to predict outcomes is critical for establishing treatment plans tailored to an individual’s genetic profile, thereby optimizing therapeutic efficacy.
Finally, the use of genomic data enables AI to investigate the interrelationship between genetics and the environment. A key part of this investigation involves studying the relationship between the two.
This knowledge, gained through assessing the correlation, is crucial for determining a patient’s likelihood of contracting an illness and is a critical component of developing a proactive health plan. An artificial intelligence (AI) model trained on genomic data from multiple databases may assess relationships among multiple genetic markers and develop new preventive treatments and interventions.
Integration of genomic data and AI is also beneficial in numerous other industries, such as agriculture and pharmaceutical development. Using genomic data to facilitate AI-based research efforts, scientists have developed crops/plants that are stronger, yield more fruit/food, and/or are resistant to certain diseases.
In addition, AI has enabled scientists to discover new therapeutic targets for diseases at a faster rate than before, ultimately reducing the time for a new medication to enter the marketplace.
Collectively, genomic data are required to enable future breakthroughs and discoveries using AI, as they contain the insights necessary to understand the complex nature of biological systems. As genomic data continue to be collected and analyzed, AI and genomics will drive the next generation of medical and scientific breakthroughs, improve healthcare globally, and enhance overall quality of life.
The Future Is Here: Your Role in the Genomic Revolution
A little while back, the idea of reading your own body’s genetic blueprint (containing approximately 3 billion letters) would have been deemed pure science fiction. Today, however, you understand that the key issue is no longer that there is too little access to your genetic information, but that there is too much.
You also likely realize that Artificial Intelligence can help discover underlying patterns in genomic data. The most important transition from mystery to tangible understanding will represent a significant shift in how medicine is practiced, thus transforming our healthcare from a reactive model to a proactive, individualized one.
As such, the new generation of medicine being developed using AI technologies will directly impact your current lifestyle. As such, begin learning about the possible changes to our medical system today. First, simply speak with your family about their health histories – these are the first types of genetic information.
Imagine a future where your appointments move from being based solely on symptoms to proactively planning your journey toward health and wellness. Artificial intelligence in healthcare is meant to support physicians by providing them with insights from your unique genetic code.
Your ability to develop “genetic literacy” is not dependent upon a degree in science. However, developing the skills to help yourself and your family be healthy and well is something you can choose to do if you are willing to learn and take an active role in your health and wellness.
If you remain curious about how you are progressing and continually ask questions, you will no longer simply be a patient; you will be a participant in one of the most exciting chapters in the history of human health and part of a new era in which medicine is truly personalized.
Comments 1